Stanford Non-Hodgkin Lymphoma Vaccine Study
Thank you for your interest in our non-Hodgkin lymphoma vaccine study and our recent publication in Science Translational Medicine. We hope the following announcement will provide you with additional information.
Non-Hodgkin lymphoma patients
Thank you again for your interest in this Phase I study. Early clinical trials enroll a limited number of people to determine what is the best dosage of a new treatment that can be given safely without serious side effects in humans. To learn more about clinical trials kindly review our FAQs.
This study is only open to patients with non-Hodgkin lymphoma who meet strict eligibility criteria. Please review the more detailed eligibility information for this study before contacting us. Patients who may be eligible for this study include those who have:
- Low grade non-Hodgkin lymphoma
- Ability to travel and receive treatment at Stanford for a six week period
- At least one site of disease that is accessible for injection directly into the tumor
- Carefully reviewed the full list of both inclusion and exclusion criteria here
Patients with other types of cancer
We are only recruiting patients with non-Hodgkin lymphoma for this study. If you’d like to explore other clinical trials at Stanford for which you might be eligible, please use the search box found in the upper right hand column of this page. If you’re wanting to cast a wider net clinicaltrials.gov lists many of the clinical trials that are ongoing in the United States and is searchable by location and condition.
Second opinions
We understand the desire to have your case reviewed by our experts. Though our staff is not able to comment or provide second opinions on cases via email or phone, we invite you, if you wish, to be seen in person for a second opinion. To make such an appointment, please call the Stanford Cancer Center at 650-498-6000.
International patients
It can be challenging for patients outside of the U.S. to enroll in a cancer clinical trial due to travel logistics and out of pocket costs. If you would still like to be considered for a Stanford clinical trial, please contact Stanford International Medical Services.
Animals with cancer
While we recognize that animal companions are a valued part of the family, this vaccine trial is only open to humans with non-Hodgkin lymphoma. We are not able to treat animals such as dogs or cats.
Media inquires
At the present time we are no longer accepting media interviews for this study. Should this change, we will update this webpage with the appropriate contact information.